Brief: Opgen Submits De Novo Request To The U.S. FDA For Unyvero Urinary Tract Infection Panel
18/04/2023 12:37
April 18 (Reuters) - OpGen Inc OPGN.O :
* OPGEN SUBMITS DE NOVO REQUEST TO THE U.S. FDA FOR UNYVERO
URINARY TRACT INFECTION PANEL
Source text for Eikon: ID:nGNX7smYyD
Further company coverage: OPGN.O
Recent news on CapForce
See all newsBrief: Opgen Says Financial Statements Contained Within Quarterly Report On Form 10-Q For Q1 2024 Should No Longer Be Relied Upon
Brief: Opgen Inc - Received Nasdaq Notice That Co Is Not In Compliance With Minimum Stockholders' Equity Requirement For Continued Listing
Brief: OpGen Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q
Brief: OpGen Announces 1-For-10 Reverse Stock Split
Brief: David E. Lazar Reports 19.9% Stake In Opgen Inc As Of March 25- SEC Filing